Anti-Human EGFR Recombinant Antibody(Zalutumumab)
-
产品编号
YR1134
-
别名
科研级 Zalutumumab ( 扎芦木单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Zalutumumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1134 |
| Alias | 科研级 Zalutumumab ( 扎芦木单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Zalutumumab |
| Size | 1mg, 5mg |
| Molecular Name | Zalutumumab |
| CAS Number | 667901-13-5 |
| Molecular Weight | 146.64 kDa |
| Target | EGFR[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. |
| Application | ELISA, FCM, IP, FuncS, IF, Neut |
| Remarks | This product is for research use only. |
0